[Federal Register Volume 81, Number 80 (Tuesday, April 26, 2016)]
[Notices]
[Page 24596]
[FR Doc No: 2016-09577]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[FRL 9944-02-OEI]

Cross-Media Electronic Reporting: Authorized Program Revision
Approval, State of Oregon

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice announces EPA's approval of the State of Oregon's
request to revise its National Primary Drinking Water Regulations
Implementation EPA-authorized program to allow electronic reporting.

DATES: EPA's approval is effective May 26, 2016 for the State of
Oregon's National Primary Drinking Water Regulations Implementation
program, if no timely request for a public hearing is received and
accepted by the Agency.

FOR FURTHER INFORMATION CONTACT: Karen Seeh, U.S. Environmental
Protection Agency, Office of Environmental Information, Mail Stop
2823T, 1200 Pennsylvania Avenue NW., Washington, DC 20460, (202) 566-
1175<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: On October 13, 2005, the final Cross-Media
Electronic Reporting Rule (CROMERR) was published in the Federal
Register (70 FR 59848) and codified as part 3 of title 40 of the CFR.
CROMERR establishes electronic reporting as an acceptable regulatory
alternative to paper reporting and establishes requirements to assure
that electronic documents are as legally dependable as their paper
counterparts. Subpart D of CROMERR requires that state, tribal or local
government agencies that receive, or wish to begin receiving,
electronic reports under their EPA-authorized programs must apply to
EPA for a revision or modification of those programs and obtain EPA
approval. Subpart D provides standards for such approvals based on
consideration of the electronic document receiving systems that the
state, tribe, or local government will use to implement the electronic
reporting. Additionally, Sec.  3.1000(b) through (e) of 40 CFR part 3,
subpart D provides special procedures for program revisions and
modifications to allow electronic reporting, to be used at the option
of the state, tribe or local government in place of procedures
available under existing program-specific authorization regulations. An
application submitted under the subpart D procedures must show that the
state, tribe or local government has sufficient legal authority to
implement the electronic reporting components of the programs covered
by the application and will use electronic document receiving systems
that meet the applicable subpart D requirements.
    On February 29, 2016, the Oregon Health Authority (OHA) submitted
an application titled Compliance Monitoring Data Portal for revision to
its EPA-approved drinking water program under title 40 CFR to allow new
electronic reporting. EPA reviewed OHA's request to revise its EPA-
authorized program and, based on this review, EPA determined that the
application met the standards for approval of authorized program
revision set out in 40 CFR part 3, subpart D. In accordance with 40 CFR
3.1000(d), this notice of EPA's decision to approve Oregon's request to
revise its Part 142--National Primary Drinking Water Regulations
Implementation program to allow electronic reporting under 40 CFR part
141 is being published in the Federal Register.
    OHA was notified of EPA's determination to approve its application
with respect to the authorized program listed above.
    Also, in today's notice, EPA is informing interested persons that
they may request a public hearing on EPA's action to approve the State
of Oregon's request to revise its authorized public water system
program under 40 CFR part 142, in accordance with 40 CFR 3.1000(f).
Requests for a hearing must be submitted to EPA within 30 days of
publication of today's Federal Register notice. Such requests should
include the following information:
    (1) The name, address and telephone number of the individual,
organization or other entity requesting a hearing;
    (2) A brief statement of the requesting person's interest in EPA's
determination, a brief explanation as to why EPA should hold a hearing,
and any other information that the requesting person wants EPA to
consider when determining whether to grant the request;
    (3) The signature of the individual making the request, or, if the
request is made on behalf of an organization or other entity, the
signature of a responsible official of the organization or other
entity.
    In the event a hearing is requested and granted, EPA will provide
notice of the hearing in the Federal Register not less than 15 days
prior to the scheduled hearing date. Frivolous or insubstantial
requests for hearing may be denied by EPA. Following such a public
hearing, EPA will review the record of the hearing and issue an order
either affirming today's determination or rescinding such
determination. If no timely request for a hearing is received and
granted, EPA's approval of the State of Oregon's request to revise its
part 142--National Primary Drinking Water Regulations Implementation
program to allow electronic reporting will become effective 30 days
after today's notice is published, pursuant to CROMERR section
3.1000(f)(4).

Matthew Leopard,
Director, Office of Information Collection.
[FR Doc. 2016-09577 Filed 4-25-16; 8:45 am]
 BILLING CODE 6560-50-P


[Federal Register Volume 77, Number 192 (Wednesday, October 3, 2012)]
[Notices]
[Pages 60440-60441]
[FR Doc No: 2012-24214]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2012-N-0001]

Clinical Investigator Training Course

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration's (FDA) Center for Drug
Evaluation and Research/Office of Medical Policy and the Duke
University Office of Continuing Medical Education are cosponsoring a 3-
day training course for clinical investigators on scientific, ethical,
and regulatory aspects of clinical trials. This training course is
intended to provide clinical investigators with expertise in the
design, conduct, and analysis of clinical trials; improve the quality
of clinical trials; and enhance the safety of trial participants.
Senior FDA staff will communicate directly with clinical investigators
on issues of greatest importance for successful clinical research.
    Date and Time: The training course will be held on November 13 and
14, 2012, from 8 a.m. to 5 p.m., and on November 15, 2012, from 8 a.m.
to 4 p.m.
    Location: The course will be held at the Holiday Inn College Park,
10000 Baltimore Ave., College Park, MD 20740.
    Contact Person: Connie Wisner, Office of Medical Policy, Center for
Drug Evaluation and Research, Food and Drug Administration, 10903 New
Hampshire Ave., Bldg. 51, rm. 6360, Silver Spring, MD 20993, 301-796-
8509.
    Registration: Register by October 22, 2012. The registration fee is
$400 per person. The fee includes course materials and onsite lunch.
Early registration is recommended because seating is limited. There
will be no onsite registration.
    Register online for the training course at the registration Web
site: http://evm.auxserv.duke.edu/iebms/reg/reg_p1_form.aspx?oc=10&ct=DCRIINVEST&eventid=46475 or download a full-size
copy of the registration form and mail a check and completed form to:
Duke University Conference and Event Services, FDA Investigator Course
Box 90841, 101 Bryan Center, Durham, NC 27708. You will receive an
email that confirms your registration. (FDA has verified the Web site
address, but FDA is not responsible for subsequent changes to the Web
site after this document publishes in the Federal Register.)
    Attendees are responsible for their own accommodations. A block of
rooms has been reserved under ``FDA Clinical Investigator Course'' at
the Holiday Inn College Park at a reduced conference rate. Reservations
for these accommodations can be made online using the course
registration Web site mentioned previously. Click on ``registration
form.'' You will see a direct link to the hotel.
    Registration materials, payment procedures, accommodation
information, and a detailed description of the course can be found at
the registration/information Web site mentioned previously.
    If you need special accommodations due to a disability, please
contact Connie Wisner at least 7 days in advance. Persons attending the
course are advised that FDA is not responsible for providing access to
electrical outlets.

I. Background

    Clinical trial investigators play a critical role in the
development of medical products. They are responsible for ensuring the
safe and ethical treatment of study subjects and for collecting
adequate and reliable data to support regulatory decisions. This course
is intended to assist clinical investigators in understanding what
preclinical and clinical information is needed to support the
investigational use of medical products, as well as the scientific,
regulatory, and ethical considerations involved in the conduct of
clinical trials. The course will cover a wide variety of key topics,
including material on novel safety concerns, adverse event monitoring,
compliance with the legal and ethical obligations of clinical research,
and acceptable scientific and analytic standards in the design and
conduct of clinical studies. The faculty will include a diverse
representation of senior FDA staff, enabling FDA to communicate
directly with clinical investigators on issues of greatest importance
for successful clinical research.

II. Description of the Training Course

A. Purpose

    The training course is designed to provide clinical investigators
with an overview of the following information:
     The essential toxicological, pharmacological, and
manufacturing data to support investigational drug use in humans;
     Fundamental issues in the design and conduct of clinical
trials;
     Statistical and analytic considerations in the
interpretation of trial data;
     Appropriate safety evaluation during studies; and
     The ethical considerations and regulatory requirements for
clinical trials.
    In addition, the course should do the following:
     Foster a cadre of clinical investigators with knowledge,
experience, and commitment to investigational medicine;
     Promote communication between clinical investigators and
FDA;
     Enhance investigators' understanding of FDA's role in
experimental medicine; and
     Improve the quality of data while enhancing subject
protection in the performance of clinical trials.

B. Proposed Agenda

    The course will be conducted over 3 days and comprised of
approximately 26 lectures, each lasting between 30 and

45 minutes. The course will be presented mainly by senior FDA staff,
with guest lecturers presenting selected topics.
    The course will address FDA's role in clinical studies, regulatory
considerations for clinical trials, and review of the material
generally appearing in an ``investigator's brochure,'' i.e., the
preclinical information (toxicology, animal studies, and chemistry/
manufacturing information) that supports initial clinical trials in
humans. Presenters will discuss the role of clinical pharmacology in
early clinical studies and how this information is used in the design
of subsequent studies. The course will also include discussions of
scientific, statistical, ethical, and regulatory aspects of clinical
studies. On November 15, 2012, participants will choose among three
breakout sessions that will explain how to put together an application
to FDA for drugs, biologics, or devices.

C. Target Audience

    The course is targeted at health care professionals responsible
for, or involved in, the conduct and/or design of clinical trials.

    Dated: September 26, 2012.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2012-24214 Filed 10-2-12; 8:45 am]
BILLING CODE 4160-01-P


[Federal Register Volume 85, Number 168 (Friday, August 28, 2020)]
[Notices]
[Pages 53355-53356]
[FR Doc No: 2020-18993]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. CP20-50-000; Docket No. CP20-51-000]

Tennessee Gas Pipeline Company, LLC, Southern Natural Gas
Company, LLC; Notice of Availability of the Environmental Assessment
for the Proposed Evangeline Pass Expansion Project

    The staff of the Federal Energy Regulatory Commission (FERC or
Commission) has prepared an environmental assessment (EA) for the
Evangeline Pass Expansion Project, proposed by Tennessee Gas Pipeline

Company, LLC (Tennessee) and Southern Natural Gas Company, LLC (SNG) in
the above-referenced dockets.
    Tennessee requests authorization to construct and operate a total
of approximately 13 miles of 36-inch-diameter looping pipeline: \1\
Yscloskey Toca Lateral Loop (about 9 miles) in St. Bernard Parish,
Louisiana and Grand Bayou Loop (about 4 miles) in Plaquemines Parish,
Louisiana. Additionally, Tennessee requests authorization to construct
and operate a new 23,470 horsepower (hp) compressor station (Compressor
Station [CS] 529) in St. Bernard Parish, Louisiana.
---------------------------------------------------------------------------

    \1\ A pipeline loop is a segment of pipe constructed parallel to
an existing pipeline to increase capacity.
---------------------------------------------------------------------------

    SNG requests authorization to construct and operate a new 22,220 hp
compressor station (Rose Hill CS) in Clarke County, Mississippi and
three new meter stations: Rose Hill Receipt Meter Station (MS) in
Clarke County, Mississippi, MEP Receipt MS in Smith County,
Mississippi, and Toca Delivery MS in St. Bernard Parish, Louisiana. SNG
is also requesting authorization to abandon the new capacity by lease
to Tennessee.
    The proposed projects, collectively known as the Evangeline Pass
Expansion Project, would provide up to 1,100,000 dekatherms per day to
the Venture Global Gator Express Pipeline interconnect for feed gas for
the Plaquemines Liquified Natural Gas Terminal in Plaquemines Parish,
Louisiana.
    The EA assesses the potential environmental effects of the
construction and operation of the projects in accordance with the
requirements of the National Environmental Policy Act. The FERC staff
concludes that approval of the proposed projects, with appropriate
mitigating measures, would not constitute a major federal action
significantly affecting the quality of the human environment.
    The Commission mailed a copy of the Notice of Availability to
federal, state, and local government representatives and agencies;
elected officials; environmental and public interest groups; Native
American tribes; potentially affected landowners and other interested
individuals and groups; and newspapers and libraries in the project
area. The EA is only available in electronic format. It may be viewed
and downloaded from the FERC's website (www.ferc.gov), on the natural
gas environmental documents page (https://www.ferc.gov/industries-data/natural-gas/environment/environmental-documents). In addition, the EA
may be accessed by using the eLibrary link on the FERC's website. Click
on the eLibrary link (https://www.ferc.gov/ferc-online/elibrary/overview), select General Search and enter the docket number in the
Docket Number field, excluding the last three digits (i.e. CP20-50 or
CP20-51). Be sure you have selected an appropriate date range. For
assistance, please contact FERC Online Support at
<EMAIL_ADDRESS>or toll free at<PHONE_NUMBER>, or for TTY,
contact<PHONE_NUMBER>.
    The EA is not a decision document. It presents Commission staff's
independent analysis of the environmental issues for the Commission to
consider when addressing the merits of issues raised in this
proceeding. Any person wishing to comment on the EA may do so. Your
comments should focus on the EA's disclosure and discussion of
potential environmental effects, reasonable alternatives, and measures
to avoid or lessen environmental impacts. The more specific your
comments, the more useful they will be. To ensure that the Commission
has the opportunity to consider your comments prior to making its
decision on this project, it is important that we receive your comments
in Washington, DC on or before 5:00pm Eastern Time on September 23,
2020.
    For your convenience, there are three methods you can use to file
your comments with the Commission. The Commission encourages electronic
filing of comments and has staff available to assist you at (866) 208-
3676 or<EMAIL_ADDRESS>Please carefully follow these
instructions so that your comments are properly recorded.
    (1) You can file your comments electronically using the eComment
feature on the Commission's website (www.ferc.gov) under the link to
FERC Online. This is an easy method for submitting brief, text-only
comments on a project;
    (2) You can also file your comments electronically using the
eFiling feature on the Commission's website (www.ferc.gov) under the
link to FERC Online. With eFiling, you can provide comments in a
variety of formats by attaching them as a file with your submission.
New eFiling users must first create an account by clicking on
eRegister. You must select the type of filing you are making. If you
are filing a comment on a particular project, please select Comment on
a Filing; or
    (3) You can file a paper copy of your comments by mailing them to
the Commission. Be sure to reference the project docket number (CP20-
50-000 or CP20-51-000) on your letter. Submissions sent via the U.S.
Postal Service must be addressed to: Kimberly D. Bose, Secretary,
Federal Energy Regulatory Commission, 888 First Street NE, Room 1A,
Washington, DC 20426. Submissions sent via any other carrier must be
addressed to: Kimberly D. Bose, Secretary, Federal Energy Regulatory
Commission, 12225 Wilkins Avenue, Rockville, Maryland 20852.
    Filing environmental comments will not give you intervenor status,
but you do not need intervenor status to have your comments considered.
Only intervenors have the right to seek rehearing or judicial review of
the Commission's decision. At this point in this proceeding, the
timeframe for filing timely intervention requests has expired. Any
person seeking to become a party to the proceeding must file a motion
to intervene out-of-time pursuant to Rule 214(b)(3) and (d) of the
Commission's Rules of Practice and Procedures (18 CFR 385.214(b)(3) and
(d)) and show good cause why the time limitation should be waived.
Motions to intervene are more fully described at https://www.ferc.gov/ferc-online/ferc-online/how-guides.
    Additional information about the project is available from the
Commission's Office of External Affairs, at (866) 208-FERC, or on the
FERC website (www.ferc.gov) using the eLibrary link. The eLibrary link
also provides access to the texts of all formal documents issued by the
Commission, such as orders, notices, and rulemakings.
    In addition, the Commission offers a free service called
eSubscription which allows you to keep track of all formal issuances
and submittals in specific dockets. This can reduce the amount of time
you spend researching proceedings by automatically providing you with
notification of these filings, document summaries, and direct links to
the documents. Go to https://www.ferc.gov/ferc-online/overview to
register for eSubscription.

    Dated: August 24, 2020.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2020-18993 Filed 8-27-20; 8:45 am]
BILLING CODE 6717-01-P


The Motor Vehicle Manufacturing Industry Applying Aluminum Parts --

Total Zinc Data

Facility Name	City	State	Sample Date	Sample ID	Duplicate Indicator Constituent Name	Total Actual or Calculated	Analytical Method	Total Concentration Result	Total Concentation Units	Total Non-Detect Indicator Total Detection Limit mg/kg	Total Detection Limit Data Qualifier Description

BMW Manufacturing Corporation	SPARTANBURG	SC

Comp-1	N	zinc	actual

15000	mg/kg

	?	Unknown

	BMW Manufacturing Corporation	SPARTANBURG	SC

Comp-2	N	zinc	actual

15100	mg/kg

	?	Unknown

	BMW Manufacturing Corporation	SPARTANBURG	SC

Comp-3	N	zinc	actual

14000	mg/kg

	?	Unknown

	BMW Manufacturing Corporation	SPARTANBURG	SC

Comp-4	N	zinc	actual

13300	mg/kg

	?	Unknown

	BMW Manufacturing Corporation	SPARTANBURG	SC

Dup-00101 (Comp-2)	Y	zinc	actual

14300	mg/kg

	?	Unknown

	DaimlerChrysler Jefferson North Assembly Plant	DETROIT	MI

JN-1	N	zinc	actual

14400	mg/kg

	DaimlerChrysler Jefferson North Assembly Plant	DETROIT	MI

JN-2	N	zinc	actual

12000	mg/kg

	DaimlerChrysler Jefferson North Assembly Plant	DETROIT	MI

JN-3	N	zinc	actual

11100	mg/kg

	DaimlerChrysler Jefferson North Assembly Plant	DETROIT	MI

JN-4	N	zinc	actual

14100	mg/kg

	DaimlerChrysler Jefferson North Assembly Plant	DETROIT	MI

JN-5	N	zinc	actual

13400	mg/kg

	DaimlerChrysler Jefferson North Assembly Plant	DETROIT	MI

JN-6	N	zinc	actual

13300	mg/kg

	DaimlerChrysler Jefferson North Assembly Plant	DETROIT	MI

JN-7	N	zinc	actual

14700	mg/kg

	Ford MI Truck/Wayne Integrated Stamping & Assembly	WAYNE	MI

Drum #2	N	zinc	actual

10300	mg/kg

5

	Ford MI Truck/Wayne Integrated Stamping & Assembly	WAYNE	MI

Drum #2 Duplicate	Y	zinc	actual

9320	mg/kg

5

	Ford MI Truck/Wayne Integrated Stamping & Assembly	WAYNE	MI

Drum #3	N	zinc	actual

7630	mg/kg

5

	Ford MI Truck/Wayne Integrated Stamping & Assembly	WAYNE	MI

Drum #4	N	zinc	actual

7400	mg/kg

5

	Ford MI Truck/Wayne Integrated Stamping & Assembly	WAYNE	MI

Drum #5	N	zinc	actual

7660	mg/kg

5

	Ford MI Truck/Wayne Integrated Stamping & Assembly	WAYNE	MI

Drum #6	N	zinc	actual

6570	mg/kg

5

	Ford Wixom Assembly Plant	WIXOM	MI

Drum #1	N	zinc	actual

1630	mg/kg

5

	Ford Wixom Assembly Plant	WIXOM	MI

Drum #2	N	zinc	actual

2660	mg/kg

5

	Ford Wixom Assembly Plant	WIXOM	MI

Drum #2 Duplicate	Y	zinc	actual

2370	mg/kg

5

	Ford Wixom Assembly Plant	WIXOM	MI

Drum #3	N	zinc	actual

2010	mg/kg

5

	Ford Wixom Assembly Plant	WIXOM	MI

Drum #4	N	zinc	actual

2300	mg/kg

5

	Ford Wixom Assembly Plant	WIXOM	MI

Drum #5	N	zinc	actual

2010	mg/kg

5

	Ford Wixom Assembly Plant	WIXOM	MI

Drum #6	N	zinc	actual

2200	mg/kg

5

	GM Flint Truck	FLINT	MI

FT-1	N	zinc	actual

1850	mg/kg

	GM Flint Truck	FLINT	MI

FT-2	N	zinc	actual

2510	mg/kg

	GM Flint Truck	FLINT	MI

FT-3	N	zinc	actual

3130	mg/kg

	GM Flint Truck	FLINT	MI

FT-4	N	zinc	actual

2640	mg/kg

	GM Flint Truck	FLINT	MI

FT-5	N	zinc	actual

2390	mg/kg

	GM Flint Truck	FLINT	MI

FT-6	N	zinc	actual

2920	mg/kg

	GM Flint Truck	FLINT	MI

FT-7	N	zinc	actual

2510	mg/kg

	GM Grand River Plant	LANSING	MI

LGR-1	N	zinc	actual

4970	mg/kg

	GM Grand River Plant	LANSING	MI

LGR-2	N	zinc	actual

1600	mg/kg

	GM Grand River Plant	LANSING	MI

LGR-3	N	zinc	actual

3500	mg/kg

	GM Grand River Plant	LANSING	MI

LGR-4	N	zinc	actual

5910	mg/kg

	GM Grand River Plant	LANSING	MI

LGR-5	N	zinc	actual

5350	mg/kg

	GM Grand River Plant	LANSING	MI

LGR-6	N	zinc	actual

6230	mg/kg

	GM Grand River Plant	LANSING	MI

LGR-7	N	zinc	actual

1590	mg/kg

	GM Hamtramck Plant	DETROIT	MI

H1-1	N	zinc	actual

5080	mg/kg

	GM Hamtramck Plant	DETROIT	MI

H1-2	N	zinc	actual

4720	mg/kg

	GM Hamtramck Plant	DETROIT	MI

H1-3	N	zinc	actual

4400	mg/kg

	GM Hamtramck Plant	DETROIT	MI

H1-4	N	zinc	actual

5130	mg/kg

	GM Hamtramck Plant	DETROIT	MI

H1-5	N	zinc	actual

4570	mg/kg

	GM Hamtramck Plant	DETROIT	MI

H1-6	N	zinc	actual

5130	mg/kg

	GM Hamtramck Plant	DETROIT	MI

H1-7	N	zinc	actual

4980	mg/kg

	GM Hamtramck Plant	DETROIT	MI

H2-1	N	zinc	actual

7180	mg/kg

	GM Hamtramck Plant	DETROIT	MI

H2-2	N	zinc	actual

6620	mg/kg

	GM Hamtramck Plant	DETROIT	MI

H2-3	N	zinc	actual

7130	mg/kg

	GM Hamtramck Plant	DETROIT	MI

H2-4	N	zinc	actual

9180	mg/kg

	GM Hamtramck Plant	DETROIT	MI

H2-5	N	zinc	actual

7360	mg/kg

	GM Hamtramck Plant	DETROIT	MI

H2-6	N	zinc	actual

8220	mg/kg

	GM Hamtramck Plant	DETROIT	MI

H2-7	N	zinc	actual

8960	mg/kg

	GM Lansing Assembly Center	LANSING	MI	12/19/1997	LAN-S01-01	N	zinc actual	Method 6020	13100	mg/kg

	GM Lansing Assembly Center	LANSING	MI	12/19/1997	LAN-S01-02	N	zinc actual	Method 6020	17400	mg/kg

	GM Lansing Assembly Center	LANSING	MI	12/19/1997	LAN-S01-03	N	zinc actual	Method 6020	16300	mg/kg

	GM Lansing Assembly Center	LANSING	MI	1/29/1998	LAN-S02-01	N	zinc actual	Method 6020	16800	mg/kg

	GM Lansing Assembly Center	LANSING	MI	1/29/1998	LAN-S02-02	N	zinc actual	Method 6020	9310	mg/kg

	J	Estimate

	GM Lansing Assembly Center	LANSING	MI	1/29/1998	LAN-S02-03	N	zinc actual	Method 6020	14000	mg/kg

	J	Estimate

	GM Lordstown Assembly Plant	LORDSTOWN	OH	12/16/1997	LOR-S01-01	N	zinc actual

8180	mg/kg

	J	Estimate

	GM Lordstown Assembly Plant	LORDSTOWN	OH	12/16/1997	LOR-S01-02	N	zinc actual

8260	mg/kg

	J	Estimate

	GM Lordstown Assembly Plant	LORDSTOWN	OH	12/16/1997	LOR-S01-03	N	zinc actual

6430	mg/kg

	GM Lordstown Assembly Plant	LORDSTOWN	OH	12/16/1997	LOR-S01-04	N	zinc actual

8670	mg/kg

	J	Estimate

	GM Lordstown Assembly Plant	LORDSTOWN	OH	12/16/1997	LOR-S01-05	N	zinc actual

6040	mg/kg

	J	Estimate

	GM Lordstown Assembly Plant	LORDSTOWN	OH	6/9/1998	LOR-S02-01	N	zinc actual

15100	mg/kg

	J	Estimate

	GM Lordstown Assembly Plant	LORDSTOWN	OH	6/9/1998	LOR-S02-02	N	zinc actual

16300	mg/kg

	J	Estimate

	GM Oklahoma City	OKLAHOMA CITY	OK	12/16/1997	OKL-S01-01	N	zinc	actual

12000	mg/kg

	GM Oklahoma City	OKLAHOMA CITY	OK	12/16/1997	OKL-S01-02	N	zinc	actual

11600	mg/kg

	GM Oklahoma City	OKLAHOMA CITY	OK	12/16/1997	OKL-S01-03	N	zinc	actual

7020	mg/kg

	GM Oklahoma City	OKLAHOMA CITY	OK	12/16/1997	OKL-S01-04	N	zinc	actual

6160	mg/kg

	GM Oklahoma City	OKLAHOMA CITY	OK	12/16/1997	OKL-S01-05	N	zinc	actual

7420	mg/kg

	GM Oklahoma City	OKLAHOMA CITY	OK	6/11/1998	OKL-S02-01	N	zinc	actual

15800	mg/kg

	GM Oklahoma City	OKLAHOMA CITY	OK	6/11/1998	OKL-S02-02	N	zinc	actual

15900	mg/kg

	GM Oklahoma City	OKLAHOMA CITY	OK	6/11/1998	OKL-S02-03	N	zinc	actual

17600	mg/kg

	GM Oklahoma City	OKLAHOMA CITY	OK	6/11/1998	OKL-S02-04	N	zinc	actual

10900	mg/kg

	GM Oklahoma City	OKLAHOMA CITY	OK	6/11/1998	OKL-S02-05	N	zinc	actual

12500	mg/kg

	GM Orion Assembly Center	LAKE ORION	MI	2/20/1995	UPCU 4103788/255-008 - RB-4	N	zinc	actual

5600	mg/kg

	GM Orion Assembly Center	LAKE ORION	MI	2/20/1995	UPCU<PHONE_NUMBER>-007 - RB-3	N	zinc	actual

7400	mg/kg

	GM Orion Assembly Center	LAKE ORION	MI	2/20/1995	UPCU 4108183/255-002 - RB-3-Dup	Y	zinc	actual

9300	mg/kg

	GM Orion Assembly Center	LAKE ORION	MI	2/20/1995	UPCU 4108183/255-003 - RB-1	N	zinc	actual

5300	mg/kg

	GM Orion Assembly Center	LAKE ORION	MI	2/20/1995	UPCU 4117098/255-004 - RB-2	N	zinc	actual

5300	mg/kg

	GM Orion Assembly Center	LAKE ORION	MI	2/21/1996	WWTP filter press cake N	zinc	actual

3550	mg/kg

2500

	GM Pontiac East Plant	PONTIAC	MI

PE-1	N	zinc	actual

8690	mg/kg

	J	Estimate

	GM Pontiac East Plant	PONTIAC	MI

PE-2	N	zinc	actual

3980	mg/kg

	J	Estimate

	GM Pontiac East Plant	PONTIAC	MI

PE-3	N	zinc	actual

3200	mg/kg

	J	Estimate

	GM Pontiac East Plant	PONTIAC	MI

PE-4	N	zinc	actual

5770	mg/kg

	J	Estimate

	GM Pontiac East Plant	PONTIAC	MI

PE-5	N	zinc	actual

2830	mg/kg

	J	Estimate

	GM Pontiac East Plant	PONTIAC	MI

PE-6	N	zinc	actual

3080	mg/kg

	J	Estimate

	GM Pontiac East Plant	PONTIAC	MI

PE-7	N	zinc	actual

3360	mg/kg

	J	Estimate

	n 	89

MAXIMUM	17600

MEAN	7917.64

MEDIAN	7130

Std. Dev.	4680.722

	90th Percentile	15020

50th Percentile	7130